WILMINGTON, Mass. (AP) — WILMINGTON, Mass. (AP) — Charles River Laboratories International Inc. (CRL) on Wednesday reported a loss of $215.7 million in its fourth quarter.
The Wilmington, Massachusetts-based company said it had a loss of $4.22 per share. Earnings, adjusted for non-recurring costs, were $2.66 per share.
The results topped Wall Street expectations. The average estimate of eight analysts surveyed by Zacks Investment Research was for earnings of $2.50 per share.
The medical research equipment and services provider posted revenue of $1 billion in the period, which also beat Street forecasts. Six analysts surveyed by Zacks expected $975.3 million.
For the year, the company reported profit of $10.3 million, or 20 cents per share. Revenue was reported as $4.05 billion.
Charles River expects full-year earnings in the range of $9.10 to $9.60 per share.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CRL at https://www.zacks.com/ap/CRL
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.